U.S. markets closed

Mustang Bio, Inc. (MBIO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.9200+0.0600 (+2.10%)
At close: 4:00PM EDT
2.9000 -0.02 (-0.68%)
After hours: 06:35PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.8600
Open2.8900
Bid2.7800 x 2900
Ask2.9200 x 4000
Day's Range2.8390 - 2.9300
52 Week Range2.4200 - 5.2200
Volume733,480
Avg. Volume1,730,049
Market Cap254.955M
Beta (5Y Monthly)1.72
PE Ratio (TTM)N/A
EPS (TTM)-1.0150
Earnings DateAug 09, 2021 - Aug 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • 15 Best Penny Stocks to Buy Now
    Insider Monkey

    15 Best Penny Stocks to Buy Now

    In this article, we discuss the 15 best penny stocks to buy now. If you want to skip our detailed analysis of these companies, go directly to the 5 Best Penny Stocks to Buy Now. Many novice investors are bullish on penny stocks with growth potential for capital appreciation. All iconic stocks were once penny […]

  • Mustang Bio Awarded Massachusetts Life Sciences Center Tax Incentive
    GlobeNewswire

    Mustang Bio Awarded Massachusetts Life Sciences Center Tax Incentive

    WORCESTER, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that it was one of 28 recipients awarded tax incentives from the Massachusetts Life Sciences Center (“MLSC”). The $300,000 tax incentive amount that Mustang was awarded is based

  • Mustang Bio to Present at the Raymond James Human Health Innovation Conference
    GlobeNewswire

    Mustang Bio to Present at the Raymond James Human Health Innovation Conference

    WORCESTER, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will present at the Raymond James Human Health Innovation Conference, taking place virtually from June 21 - 23